虽然恶性淋巴瘤的治愈率近年有了很大提高,然而,微小残留病变的存在以及对化疗初始或继发耐药性,使得许多患者临床缓解(CR)后仍会复发,特别是T细胞淋巴瘤疗效尚不令人满意,因此,迫切需要寻找治愈淋巴瘤的新方法。淋巴细胞表面常表达免疫球蛋白(Ig)或T细胞受体(TCR)分子,存 Although the cure rate of malignant lymphoma has greatly improved in recent years, however, the presence of minimal residual disease and the initial or secondary resistance to chemotherapy, many patients will still relapse after clinical remission (CR), especially T cell lymphoid The curative effect of tumors is not yet satisfactory, so there is an urgent need to find new ways to cure lymphoma. The surface of lymphocytes often express immunoglobulin (Ig) or T cell receptor (TCR) molecules.